Research and clinical experience show that targeting the persistent redness (erythema) of rosacea, in combination with treating all signs and symptoms individually, may not only clear its appearance but also lessen the severity of the disease itself, according to Dr. Julie Harper, president and owner of the Dermatology and Skin Care Center of Birmingham.

“We’re on the cusp of really changing how we treat rosacea,” Dr. Harper said.

New recommendations urging dermatologists to place greater emphasis on persistent redness in rosacea were recently published in the Journal of Drugs in Dermatology. Titled “Update on Facial Erythema in Rosacea,” the article was based on a recent NRS roundtable to discuss this key aspect of the disorder in light of its recently updated standard classification system and standard management options, new burden-of-illness study results, and significant advances in medical therapy and patient care.

New developments in rosacea call for dermatologists to place greater emphasis on addressing persistent facial redness (erythema), according to experts at a recent National Rosacea Society (NRS) roundtable to provide an update on this key aspect of the disorder. The roundtable participants discussed the new standard classification system,¹ recent burden-of-illness study results, new standard management options and significant advances in medical therapy and patient care.